EPO: Cost-Effectiveness

• The degree of improvement in QOL must be balanced against the additional cost of achieving a higher hematocrit level and the increased risk of potential adverse effects:

  • hypertension
  • vascular access clotting

Previous slide

Next slide

Back to first slide

View graphic version

Epoetin Alfa Improves Quality of Life Drug & Ther Perspect 11(5):14-16, 1998. © 1998 Adis International Limited